Zsírmáj (MASLD/MASH): vizsgálatok itt: Dánia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Where
- Copenhagen Nv, Hvidovre
- Életkor
- 18 év and over
- People
- 205 worldwide
- Run by
- Akero Therapeutics Inc.
See details and how to join2024-512895-36-00 · EU 2024-512895-36-00 - 3. fázisTaking peopleA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Where
- Hvidovre
- Életkor
- 18 év to 80 év
- People
- 2150 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06528314 - No phaseTaking peopleIncreased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Where
- Herlev
- Életkor
- 34 év to 49 év
- People
- 300
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT05890365 - No phaseTaking peopleIdentification of Liver Fibrosis Biomarkers
- Where
- Copenhagen
- Életkor
- 18 év to 75 év
- People
- 575 worldwide
- Run by
- Roche Diagnostics GmbH
See details and how to joinNCT06819917 - No phaseTaking peopleNon-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Where
- Aarhus, Herlev
- Életkor
- 35 év to 40 év
- People
- 8
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT05842850 - No phaseTaking peopleGlucagon Resistance in Patients With MASLD and T2DM
- Where
- Aarhus
- Életkor
- 30 év to 70 év
- People
- 24
- Run by
- University of Aarhus
See details and how to joinNCT07246421 - No phaseTaking peoplePrognostic Significance of Fatty Liver Disease in Bariatric Patients
- Where
- Esbjerg
- Életkor
- 18 év and over
- People
- 1200
- Run by
- Esbjerg Hospital - University Hospital of Southern Denmark
See details and how to joinNCT03535142 - No phaseTaking peopleScreening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers
- Where
- Odense
- Életkor
- 30 év to 75 év
- People
- 6500
- Run by
- Maja Thiele
See details and how to joinNCT03308916 - No phaseTaking peopleAn Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
- Where
- Hvidovre
- Életkor
- 18 év and over
- People
- 335
- Run by
- University of Copenhagen
See details and how to joinNCT05335603